GAZI UNIVERSITY INFORMATION PACKAGE - 2019 ACADEMIC YEAR

Course&Program L. Outcomes
 --The Matrix for Course & Program Learning Outcomes
COURSE
PROGRAM LEARNING OUTCOMES
1
2
3
4
5
6
7
8
9
10
1110999-MASTER SCIENCE THESIS PERIOD
5
5
5
5
5
5
5
5
5
5
2110999-SPECIAL STUDIES IN MSC.
5
5
5
5
5
5
5
5
5
5
6110999-THESIS PREPARATION
5
5
5
5
5
5
5
5
5
5
FTE-1002-SEMINAR
5
5
5
5
5
5
5
5
5
5
FTE-1010 -BASIC PROCESS IN THE PHARMACEUTICAL TECHNOLOGY
4
4
1
4
2
2
1
1
3
1
FTE-1011 -BASIC PROCESS IN THE PHARMACEUTICAL TECHNOLOGY-PRACTICE
4
4
1
4
2
2
1
1
3
1
FTE-1020 -PHYSICAL PHARMACY
3
4
2
2
2
3
1
3
4
2
FTE-1031 -PRE-FORMULATION – PRACTICE
5
5
4
3
5
4
4
3
5
4
FTE-1041 -KINETIC PRINCIPLES AND STABILTY-PRACTICE
5
5
4
5
5
5
4
3
5
5
FTE-1050 -PARENTERAL SOLUTION AND OTHER STERIL PRODUCT TECHNOLOGY
5
5
5
5
5
2
3
1
5
5
FTE-1051 -PARENTERAL SOLUTION AND OTHER STERIL PRODUCT TECHNOLOGY- PRACTICE
5
5
5
5
5
2
3
1
5
5
FTE-1070 -RADIOPHARMACEUTICS I
5
5
4
5
5
5
4
3
5
5
FTE-1081 -BASIC PHARMACOKINETICS AND BIOPHARMACEUTICS-PRACTICE
5
5
3
3
2
5
1
1
5
5
FTE-1090 -PHARMACEUTICAL BIOTECHNOLOGY I:BASIC PRINCIPLES
4
4
2
4
4
5
5
5
4
4
FTE-1110-SCIENTIFIC RESEARCH METHODS AND RESEARCH-PUBLICATION ETHICS
1
1
2
1
1
1
0
0
3
3
FTE-1120-PRE-FORMULATION
5
5
5
5
5
5
4
4
5
5
FTE-1130-KINETIC PRINCIPLES AND STABILITY
5
5
3
5
4
5
3
5
5
5
FTE-1140-BASIC PHARMACOKINETICS AND BIOPHARMACEUTICS
5
5
3
3
4
5
4
0
5
5
FTE-2002-SEMINAR
5
5
5
5
5
4
5
5
5
5
FTE-2020 -TABLET TECHNOLOGY
5
4
4
4
5
4
1
1
5
4
FTE-2021 -TABLET TECHNOLOGY - PRACTICE
4
5
4
4
5
4
3
4
5
5
FTE-2030 -MULTIPLE PHASE SYSTEMS
4
5
5
3
4
5
4
3
5
5
FTE-2031 -MULTIPLE PHASE SYSTEMS I –PRACTICE
4
5
5
5
5
4
4
3
5
5
FTE-2040 -CONTROLLED RELEASE DRUG DELIVERY TECHNOLOGY I.
5
5
5
4
5
4
5
3
5
5
FTE-2041 -CONTROLLED RELEASE DRUG DELIVERY TECHNOLOGY -PRACTICE
5
5
5
4
5
5
5
3
5
5
FTE-2050 -TECHNOLOGY OF SEMI SOLID DOSAGE FORMS I
5
5
4
4
5
5
5
5
5
5
FTE-2051 -TECHNOLOGY OF SEMI SOLID DOSAGE FORMS I. -PRACTICE
5
5
5
5
5
5
5
5
5
5
FTE-2090 -CELL CULTURE IN DRUG DEVELOPMENT AND EVALUATION
3
5
3
4
4
3
5
4
5
5
FTE-2140-PHARMACEUTICAL BIOTECHNOLOGY II. MONOCLONAL DRUG MANUFACTURING TECHNOLOGY
3
4
2
4
4
3
5
5
4
4
FTE-2171 -DISSOLUTION RATE AND THE RELEASE KINETIC FROM DOSAGE FORMS-PRACTICE
5
5
3
4
4
5
3
1
5
5
FTE-2180 -THE EXCIPIENTS USED IN PHARMACEUTICAL TECHNOLOGY
5
5
5
4
5
4
5
4
5
5
FTE-2190-GOOD MANUFACTURING PRACTICES AND VALIDATION
5
5
5
5
5
5
4
4
5
5
FTE-2200-DISSOLUTION RATE AND RELEASE KINETICS FROM DOSAGE FORMS
5
5
4
5
4
5
3
1
5
5
SBE-ERA-85-ERASMUS INTERNSHIP
5
5
5
5
5
5
5
5
5
5
Course number related with program competency / 34 34343434343433323434
Program competency weight 154160133143146141125107161153
* Relationship level 0 (none) and 5 (highest) are expressed in.